Coloplast A/S (ETR:CBHD)

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of EUR 17.53 billion. The enterprise value is 20.43 billion.

Market Cap	17.53B
Enterprise Value	20.43B

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	207.37M
Shares Outstanding	n/a
Shares Change (YoY)	+0.22%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	5.32%
Owned by Institutions (%)	21.57%
Float	143.59M

Valuation Ratios

The trailing PE ratio is 36.00 and the forward PE ratio is 22.53.

PE Ratio	36.00
Forward PE	22.53
PS Ratio	4.70
PB Ratio	8.12
P/TBV Ratio	n/a
P/FCF Ratio	24.52
P/OCF Ratio	19.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.11, with an EV/FCF ratio of 28.58.

EV / Earnings	41.97
EV / Sales	5.47
EV / EBITDA	17.11
EV / EBIT	19.76
EV / FCF	28.58

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 1.40.

Current Ratio	1.61
Quick Ratio	0.94
Debt / Equity	1.40
Debt / EBITDA	2.54
Debt / FCF	4.24
Interest Coverage	10.25

Financial Efficiency

Return on equity (ROE) is 21.35% and return on invested capital (ROIC) is 12.17%.

Return on Equity (ROE)	21.35%
Return on Assets (ROA)	10.01%
Return on Invested Capital (ROIC)	12.17%
Return on Capital Employed (ROCE)	18.44%
Revenue Per Employee	222,896
Profits Per Employee	29,075
Employee Count	16,744
Asset Turnover	0.58
Inventory Turnover	2.35

Taxes

In the past 12 months, Coloplast has paid 337.55 million in taxes.

Income Tax	337.55M
Effective Tax Rate	40.95%

Stock Price Statistics

The stock price has decreased by -34.93% in the last 52 weeks. The beta is 0.62, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-34.93%
50-Day Moving Average	78.16
200-Day Moving Average	85.74
Relative Strength Index (RSI)	50.91
Average Volume (20 Days)	602

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of EUR 3.73 billion and earned 486.84 million in profits. Earnings per share was 2.16.

Revenue	3.73B
Gross Profit	2.54B
Operating Income	1.03B
Pretax Income	824.39M
Net Income	486.84M
EBITDA	1.16B
EBIT	1.03B
Earnings Per Share (EPS)	2.16

Balance Sheet

The company has 126.80 million in cash and 3.03 billion in debt, giving a net cash position of -2.90 billion.

Cash & Cash Equivalents	126.80M
Total Debt	3.03B
Net Cash	-2.90B
Net Cash Per Share	n/a
Equity (Book Value)	2.16B
Book Value Per Share	9.58
Working Capital	528.61M

Cash Flow

In the last 12 months, operating cash flow was 889.73 million and capital expenditures -174.87 million, giving a free cash flow of 714.86 million.

Operating Cash Flow	889.73M
Capital Expenditures	-174.87M
Free Cash Flow	714.86M
FCF Per Share	n/a

Margins

Gross margin is 67.97%, with operating and profit margins of 27.70% and 13.04%.

Gross Margin	67.97%
Operating Margin	27.70%
Pretax Margin	22.09%
Profit Margin	13.04%
EBITDA Margin	30.96%
EBIT Margin	27.70%
FCF Margin	19.15%

Dividends & Yields

This stock pays an annual dividend of 2.95, which amounts to a dividend yield of 3.73%.

Dividend Per Share	2.95
Dividend Yield	3.73%
Dividend Growth (YoY)	4.73%
Years of Dividend Growth	9
Payout Ratio	136.36%
Buyback Yield	-0.22%
Shareholder Yield	3.51%
Earnings Yield	2.78%
FCF Yield	4.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Coloplast has an Altman Z-Score of 4.76 and a Piotroski F-Score of 7.

Altman Z-Score	4.76
Piotroski F-Score	7